Integrated Investment Consultants’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,767
Closed -$260K 329
2025
Q1
$260K Sell
1,767
-250
-12% -$36.2K 0.05% 272
2024
Q4
$264K Sell
2,017
-142
-7% -$19.9K 0.05% 251
2024
Q3
$336K Buy
+2,159
New +$349K 0.07% 212
2023
Q2
Sell
-4,428
Closed -$615K 279
2023
Q1
$615K Sell
4,428
-609
-12% -$81.9K 0.19% 83
2022
Q4
$683K Buy
5,037
+74
+1% +$9.28K 0.23% 66
2022
Q3
$545K Sell
4,963
-130
-3% -$16.5K 0.22% 72
2022
Q2
$672K Sell
5,093
-2,310
-31% -$303K 0.24% 63
2022
Q1
$982K Sell
7,403
-964
-12% -$116K 0.28% 59
2021
Q4
$976K Hold
8,367
0.26% 62
2021
Q3
$1.01M Buy
8,367
+125
+2% +$14.6K 0.3% 56
2021
Q2
$988K Buy
8,242
+3,530
+75% +$387K 0.29% 56
2021
Q1
$468K Sell
4,712
-560
-11% -$56.3K 0.16% 118
2020
Q4
$527K Buy
5,272
+450
+9% +$47.7K 0.2% 92
2020
Q3
$528K Buy
4,822
+493
+11% +$54.8K 0.25% 78
2020
Q2
$458K Sell
4,329
-790
-15% -$81.6K 0.22% 76
2020
Q1
$457K Buy
5,119
+1,046
+26% +$98.5K 0.27% 67
2019
Q4
$406K Buy
4,073
+746
+22% +$70.2K 0.17% 92
2019
Q3
$296K Buy
+3,327
New +$288K 0.15% 104
2018
Q2
Sell
-202
Closed -$14K 210
2018
Q1
$14K Buy
+202
New +$14K 0.01% 584
2016
Q4
Sell
-1,477
Closed -$91K 579
2016
Q3
$91K Sell
1,477
-901
-38% -$58.9K 0.05% 287
2016
Q2
$144K Buy
2,378
+137
+6% +$7.96K 0.08% 187
2016
Q1
$132K Buy
+2,241
New +$135K 0.08% 175

Other funds holding AZN